跳至主要内容
临床试验/EUCTR2019-001680-69-ES
EUCTR2019-001680-69-ES进行中(未招募)1 期

MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2) - MASTERS-2

Athersys, Inc.0 个研究点目标入组 300 人开始时间: 2022年7月11日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Male or female subjects =18 years of age
  • Clinical diagnosis of ischemic stroke involving cerebral cortex
  • Occurrence of a moderate to moderately severe stroke with a persistent neurologic deficit documented by a NIHSS score of 8 to 20 (inclusive) that does not change by =4 points during the initial screening period
  • A mRS score of 0 or 1 prior to the onset of symptoms of the current stroke
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 90
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 210

排除标准

  • Presence of a lacunar or a brainstem infarct
  • Comatose state
  • Brain hemorrhage
  • Major neurological event such as stroke or clinically significant head trauma within 6 months of enrollment into the study

研究者

相似试验

进行中(未招募)
1 期
MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2)
EUCTR2019-001680-69-DEAthersys, Inc.300
已完成
不适用
MAnagement for Total Stroke care and Urgent Treatment in Area of Kuchitanba Evenly (MATSUTAKE) Semi-long-term Outcome StudyStroke
JPRN-UMIN000009964antan General Hospital500
招募中
不适用
The treatment of stroke patients with severe and severest dysphagia by swallowing function stimulation with iced exercise boli: a clinical trial to evaluate a therapeutic treatment optioI63R13DysphagiaCerebral infarction
DRKS00027276Median Klinik Bad Tennstedt112
已完成
3 期
INTERVENTIONAL MANAGEMENT OF STROKE TRIAL CLINICAL PROTOCOL - IMS III A phase III, randomized, multi-center, open label, 900 subject clinical trial that will examine whether a combined intravenous (IV) and intra-arterial (IA) approach to recanalization is superior to standard IV rt-PA (Activase®/Actilyse®) alone when initiated within three hours of acute ischemic stroke onset.ischemic cerebrovascular accident1000796310014523Stroke
NL-OMON36365ational Institute of Health20
进行中(未招募)
不适用
TERVENTIONAL MANAGEMENT OF STROKE TRIAL CLINICAL PROTOCOL (IMS III study)Ischemic StrokeMedDRA version: 14.0Level: PTClassification code 10065528Term: NIH stroke scale score increasedSystem Organ Class: 10022891 - InvestigationsMedDRA version: 14.0Level: LLTClassification code 10055221Term: Ischemic strokeSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2009-017454-12-DEniversity of Cincinnati - Academic Medical Center -Department of Neurology900
MultiStem® Administration for Stroke Treatment and... | 临床试验